Feed Hedge Funds Ban Employees from Taking Ozempic August 28, 2026 0 Min Read Share 0 Min Read SHARE Several hedge funds are reportedly prohibiting employees from using Ozempic, a popular diabetes and weight-loss medication, citing concerns about potential side effects impacting job performance. Share This Article Facebook Twitter Copy Link Leave a comment Leave a comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Goldman Sachs Raises Brent Crude Oil Forecast by 17%Goldman Sachs has increased its price forecast for Brent crude oil by… Binance USDT Reserves Down 7.95% Amid Asset ConsolidationBinance's USDT reserves fell by 7.95% in October, with the exchange now… Bitcoin White Paper Celebrates 18 Years, Core Features RemainThe original Bitcoin white paper turns 18 years old, with its fundamental… Hackers Offer Hospital Patients $2,500 After Data BreachHackers who breached a hospital's systems have apologized, offering affected patients up… Hong Kong Launches 24/7 Tokenized Settlements and Stablecoin TrialsHong Kong's financial authorities are enabling round-the-clock tokenized settlement systems and planning… Ethereum Whale Buys $63 Million in ETH, Suggests Market BottomA large Ethereum holder, or 'whale,' purchased $63 million worth of ETH.…
